Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815407
Status:
COMPLETED
Last Update Posted:
2023-04-18
First Post:
2023-04-04
Brief Title:
Expressiona and Diagnostic Potential of miRNAs in NSCLC
Sponsor:
Al-Azhar University
Organization:
Al-Azhar University
Study Overview
Official Title:
The Expression Profiling of Serum miRNAs 106b-5p 601 and 760 in Non-small Cell Lung Cancer Patients
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Its to explore the expression pattern diagnostic and prognostic potentials of miRs 106b-5p 601 and 760 in serum of NSCLC patients
Detailed Description:
A retrospective observational study on NSCLC patients to determine the serum expression levels if some miRNAs in NSCLC patients and to find if having proper diagnostic and prognostic values in early disease detection andor staging
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None